Dual chamber pacing in patients with severe heart failure on β blocker and amiodarone treatment: preliminary results of a randomised study
| Autor: | H Nägele, W. Rödiger, R Schomburg, B. Petersen |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2002 |
| Předmět: |
Male
medicine.medical_specialty medicine.drug_class medicine.medical_treatment Adrenergic beta-Antagonists Carbazoles Amiodarone Propanolamines Scientific Letters Internal medicine Idiopathic dilated cardiomyopathy medicine Humans Carvedilol Beta blocker Heart transplantation Heart Failure business.industry Cardiac Pacing Artificial Mitral Valve Insufficiency Dilated cardiomyopathy Stroke Volume medicine.disease Death Sudden Cardiac Heart failure Anesthesia Adjunctive treatment Cardiology Heart Transplantation Drug Therapy Combination Female Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents medicine.drug |
| Popis: | Standard dual chamber pacing was first used as adjunctive treatment for severe congestive heart failure in the early 1990s.1 It was proposed that a short atrioventricular delay reduced presystolic mitral regurgitation.2,3 It also may correct chronotropic incompetence and protect against fatal bradyarrhythmias. We performed a randomised study to test whether DDDR pacing with optimised atrioventricular (AV) delay and reversal of drug induced bradycardia by rate responsive pacing was beneficial in heart failure patients who were receiving combined treatment with amiodarone and β blockers as empirical prophylaxis against sudden tachyarrhythmic death.4 In 82 patients with severe heart failure submitted for heart transplantation and without a conventional pacemaker indication between 1996 and 1998 (85% male; 52% idiopathic dilated cardiomyopathy), treatment with low dose amiodarone (1000 mg/week) plus titrated doses of carvedilol (target 50 mg/day) was instituted. In addition, … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|